For trauma patients with exsanguinating torso hemorrhage, resuscitative endovascular balloon occlusion of the aorta (REBOA) did not reduce mortality, and may have increased 90-day mortality, when ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Two newer ...
For patients with nontraumatic, out-of-hospital cardiac arrest (OHCA), evolving technology in the form of resuscitative endovascular balloon occlusion of the aorta, as well as expanded use of ...
U.S. Army Medical Research and Development Command Funds FORCE Study to Evaluate Advanced Hemorrhage Control Technology on the Battlefield - Prytime Medical SAN ANTONIO, Nov. 1, 2024 /PRNewswire/ -- ...
Dr. Chance Spalding uses the REBOA technique to help victims of car crashes or shootings at Grant Medical Center. A small balloon could be one of the best bets for Columbus doctors to save gunshot ...
San Antonio, TX ., Pryor Medical Devices (The REBOA Company TM), today announced it has received FDA 510(k) clearance for the sale and distribution of its ER-REBOA TM catheter. REBOA (Resuscitative ...
U.S. Department of Defense awards Prytime Medical grant to study the clinical outcomes of the world's first and only catheter designed for Partial REBOA, pREBOA-PRO™ "Partial REBOA delivered with ...
MADIGAN ARMY MEDICAL CENTER, Joint Base Lewis-McChord, Wash. -- Surgical research at Madigan Army Medical Center directly contributed to new trauma medical procedures to address the top cause of ...
LONDON, Ontario – Sept. 10, 2021 – Excessive blood loss is one of the leading causes of death in trauma patients, and trauma is the fourth leading cause of death overall for all ages. That’s where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback